Virtual ISPOR Europe 2021
We’re excited to announce that the PRECISIONadvisors team will be presenting 2 podium presentations and 7 posters at Virtual ISPOR Europe 2021 30 November- 3 December.
We’re excited to announce that the PRECISIONadvisors team will be presenting 2 podium presentations and 7 posters at Virtual ISPOR Europe 2021 30 November- 3 December.
In this webinar moderated by PRECISIONadvisor's David Carr, we are joined by European payers and industry representatives from Germany (Frank-Ulrich Fricke), Italy (Fabrizio Gianfrate) and the UK (Benit Maru and Andrew Walker) to take a look at the current regulatory and reimbursement landscape, as well as how different countries have sought and will seek to address the gap in evidence requirements between the EMA and HTA bodies.
There is no doubt that the advanced therapies sector is growing at an exponential rate. According to a recently published 2021 Report by ARM (Alliance for Regenerative Medicine), the sector has raised $14.1B in financing in the first half of 2021 which is already 71% of what was raised in all of 2020. In addition, there are over 2,600 advance therapy clinical trials being conducted with 264 of those trails being Phase 3 trials and another 1,500 being Phase 2 trials.
The Precision Value & Health family of brands is now Precision AQ
Precision AQ helps life sciences companies navigate the complexities of commercialization across a product’s lifecycle. Our team is comprised of experts, advisors, and creators working to ensure patients have access to life-changing medicines.
Our global offerings include:
Our name, which stands for Precision Access Quotient, reflects our approach to removing barriers – fusing together science (IQ, or Intelligence Quotient) and empathy (EQ, or Emotional Quotient). The result is “AQ: Access Quotient”, a critical ingredient in navigating the therapy-to-patient journey informed by data-driven analytics and insights.
To find out more about our global services and our unified mission, empowering access to life-changing medicines for all, visit: Precision AQ